Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31583 | 0.78 | MEN1 (1.00) | MEN1KMT2AKDM4ETDP1MAPT | |
| SCHEMBL29499501 | 0.78 | MEN1 (1.00) | MEN1KMT2AKDM4ETDP1MAPT | |
| Hydrochloric Acid SCHEMBL22321960 | 0.77 | MEN1 (0.97) | MEN1KMT2AKDM4ETDP1MAPT | |
| Iodide SCHEMBL22542621 | 0.77 | MEN1 (0.97) | MEN1KMT2AKDM4ETDP1MAPT | |
| Iodide SCHEMBL29456898 | 0.77 | MEN1 (0.97) | MEN1KMT2AKDM4ETDP1MAPT | |
| SCHEMBL21795198 | 0.74 | MEN1 (0.64) | MEN1KMT2AKDM4ETDP1MAPT | |
| SCHEMBL4415820 | 0.73 | MEN1 (0.62) | MEN1KMT2AKDM4ETDP1MAPT | |
| SCHEMBL14452219 | 0.72 | MEN1 (0.60) | MEN1KMT2AKDM4ETDP1MAPT | |
| SCHEMBL4417719 | 0.72 | MEN1 (0.60) | MEN1KMT2AKDM4ETDP1MAPT | |
| Hydrochloric Acid SCHEMBL4422818 | 0.71 | MEN1 (0.59) | MEN1KMT2AKDM4ETDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8232471-B2 | Squarylium dye, method of producing the same, photoelectric conversion element containing the dye, and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8232471-B2 | Squarylium dye, method of producing the same, photoelectric conversion element containing the dye, and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20080308149-A1 | SQUARYLIUM DYE, METHOD OF PRODUCING THE SAME, PHOTOELECTRIC CONVERSION ELEMENT CONTAINING THE DYE, AND SOLID-STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| US-20080308149-A1 | SQUARYLIUM DYE, METHOD OF PRODUCING THE SAME, PHOTOELECTRIC CONVERSION ELEMENT CONTAINING THE DYE, AND SOLID-STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080308149-A1 | SQUARYLIUM DYE, METHOD OF PRODUCING THE SAME, PHOTOELECTRIC CONVERSION ELEMENT CONTAINING THE DYE, AND SOLID-STATE IMAGING DEVICE | SPIN1, SQLE, FDFT1 | MEN1 784/4885KMT2A 2180/4885KDM4E 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.